Benefit-Risk Management

ONLY 1 OFFERING IN 2017! Our best-in-class instructors teach you the Do’s and Don’ts for BRM over the lifecycle of the product, and the course includes the Rev 2 of the GVP Modules V and XVI.

Back to Agenda

SESSION 9: EVALUATION OF RISK MINIMISATION EFFECTIVENESS

Session Chair(s)

Michael Von Forstner, PhD, MPH, MSc

Managing Director, Head of Pharmacoepidemiology Practice, Mesa Laubela Consulting, Switzerland

Tools and methodologies available
Levels of metrics
Required evaluation levels and examples of satisfactory results

Speaker(s)

EVALUATION OF RISK MINIMISATION EFFECTIVENESS

Michael Von Forstner, PhD, MPH, MSc

Managing Director, Head of Pharmacoepidemiology Practice, Mesa Laubela Consulting, Switzerland

Have an account?

Benefit-Risk Management

SESSION 9: EVALUATION OF RISK MINIMISATION EFFECTIVENESS

Session Chair(s)

Michael Von Forstner, PhD, MPH, MSc

Speaker(s)

Be informed and stay engaged.